162 related articles for article (PubMed ID: 29364502)
1. ARRDC3 suppresses colorectal cancer progression through destabilizing the oncoprotein YAP.
Shen X; Sun X; Sun B; Li T; Wu G; Li Y; Chen L; Liu Q; Cui M; Zhou Z
FEBS Lett; 2018 Feb; 592(4):599-609. PubMed ID: 29364502
[TBL] [Abstract][Full Text] [Related]
2. Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner.
Liu Y; Wang G; Yang Y; Mei Z; Liang Z; Cui A; Wu T; Liu CY; Cui L
Oncogene; 2016 May; 35(21):2789-800. PubMed ID: 26387538
[TBL] [Abstract][Full Text] [Related]
3. RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway.
Guo PD; Lu XX; Gan WJ; Li XM; He XS; Zhang S; Ji QH; Zhou F; Cao Y; Wang JR; Li JM; Wu H
Cancer Res; 2016 Jul; 76(13):3813-25. PubMed ID: 27325643
[TBL] [Abstract][Full Text] [Related]
4. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
[TBL] [Abstract][Full Text] [Related]
5. The α-Arrestin ARRDC3 Is an Emerging Multifunctional Adaptor Protein in Cancer.
Wedegaertner H; Pan WA; Gonzalez CC; Gonzalez DJ; Trejo J
Antioxid Redox Signal; 2022 May; 36(13-15):1066-1079. PubMed ID: 34465145
[No Abstract] [Full Text] [Related]
6. Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression.
Zhong X; Lü M; Wan J; Zhou T; Qin B
Biomed Pharmacother; 2018 Nov; 107():382-389. PubMed ID: 30099342
[TBL] [Abstract][Full Text] [Related]
7. YAP-dependent ubiquitination and degradation of β-catenin mediates inhibition of Wnt signalling induced by Physalin F in colorectal cancer.
Chen C; Zhu D; Zhang H; Han C; Xue G; Zhu T; Luo J; Kong L
Cell Death Dis; 2018 May; 9(6):591. PubMed ID: 29789528
[TBL] [Abstract][Full Text] [Related]
8. Netrin-1 exerts oncogenic activities through enhancing Yes-associated protein stability.
Qi Q; Li DY; Luo HR; Guan KL; Ye K
Proc Natl Acad Sci U S A; 2015 Jun; 112(23):7255-60. PubMed ID: 26039999
[TBL] [Abstract][Full Text] [Related]
9. Elevation of YAP promotes the epithelial-mesenchymal transition and tumor aggressiveness in colorectal cancer.
Ling HH; Kuo CC; Lin BX; Huang YH; Lin CW
Exp Cell Res; 2017 Jan; 350(1):218-225. PubMed ID: 27914787
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
Sun M; Song H; Wang S; Zhang C; Zheng L; Chen F; Shi D; Chen Y; Yang C; Xiang Z; Liu Q; Wei C; Xiong B
J Hematol Oncol; 2017 Mar; 10(1):79. PubMed ID: 28356122
[TBL] [Abstract][Full Text] [Related]
11. HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development.
Qian F; Xiao J; Gai L; Zhu J
Mol Carcinog; 2019 Apr; 58(4):500-510. PubMed ID: 30456802
[TBL] [Abstract][Full Text] [Related]
12. YAP inhibits autophagy and promotes progression of colorectal cancer via upregulating Bcl-2 expression.
Jin L; Chen Y; Cheng D; He Z; Shi X; Du B; Xi X; Gao Y; Guo Y
Cell Death Dis; 2021 May; 12(5):457. PubMed ID: 33963173
[TBL] [Abstract][Full Text] [Related]
13. The α-arrestin ARRDC3 suppresses breast carcinoma invasion by regulating G protein-coupled receptor lysosomal sorting and signaling.
Arakaki AKS; Pan WA; Lin H; Trejo J
J Biol Chem; 2018 Mar; 293(9):3350-3362. PubMed ID: 29348172
[TBL] [Abstract][Full Text] [Related]
14. Increased proton-sensing receptor GPR4 signalling promotes colorectal cancer progression by activating the hippo pathway.
Yu M; Cui R; Huang Y; Luo Y; Qin S; Zhong M
EBioMedicine; 2019 Oct; 48():264-276. PubMed ID: 31530502
[TBL] [Abstract][Full Text] [Related]
15. miR-375-3p suppresses tumorigenesis and partially reverses chemoresistance by targeting YAP1 and SP1 in colorectal cancer cells.
Xu X; Chen X; Xu M; Liu X; Pan B; Qin J; Xu T; Zeng K; Pan Y; He B; Sun H; Sun L; Wang S
Aging (Albany NY); 2019 Sep; 11(18):7357-7385. PubMed ID: 31543507
[TBL] [Abstract][Full Text] [Related]
16. E2A suppresses invasion and migration by targeting YAP in colorectal cancer cells.
Zhao H; Huang A; Li P; Quan Y; Feng B; Chen X; Mao Z; Zhu Z; Zheng M
J Transl Med; 2013 Dec; 11():317. PubMed ID: 24369055
[TBL] [Abstract][Full Text] [Related]
17. Clinical and prognostic significance of Yes-associated protein in colorectal cancer.
Wang Y; Xie C; Li Q; Xu K; Wang E
Tumour Biol; 2013 Aug; 34(4):2169-74. PubMed ID: 23558963
[TBL] [Abstract][Full Text] [Related]
18. α-Arrestin ARRDC3 tumor suppressor function is linked to GPCR-induced TAZ activation and breast cancer metastasis.
Arakaki AKS; Pan WA; Wedegaertner H; Roca-Mercado I; Chinn L; Gujral TS; Trejo J
J Cell Sci; 2021 Apr; 134(8):. PubMed ID: 33722977
[TBL] [Abstract][Full Text] [Related]
19. Loss of HACE1 promotes colorectal cancer cell migration via upregulation of YAP1.
Zhou Z; Zhang HS; Zhang ZG; Sun HL; Liu HY; Gou XM; Yu XY; Huang YH
J Cell Physiol; 2019 Jun; 234(6):9663-9672. PubMed ID: 30362561
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m
Ni W; Yao S; Zhou Y; Liu Y; Huang P; Zhou A; Liu J; Che L; Li J
Mol Cancer; 2019 Oct; 18(1):143. PubMed ID: 31619268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
